Author Guideline

All submitted manuscripts should contain original research not previously published and not under consideration for publication elsewhere. Papers may come from any country but must be written in English. Electronic reprints of related published papers by the authors or manuscripts in press may also be helpful to the reviewers.

AIMS AND SCOPE

BIOPHARM JOURNAL is a bimonthly international journal publishing high quality manuscript which devoted to the advancement of scientific knowledge concerning medical, biological, pharmaceutical and chemical Sciences and related academic disciplines.

It covers scientific and technological aspects of

  • Biological Science: Plant biology, animal biology, microbiology, molecular biology; bioactive compounds, chemical biology; biocatalysis, fermentation technology and biotechnology; bioprocess, environmental microbiology and engineering, biological waste treatment, drug targeting, enzyme inhibitors, receptor, biological chemistry and life sciences.

  • Pharmaceutical Science: Pharmaceutics, Pharmaceutical Technology, Biopharmaceutics, Industrial pharmacy, Cosmetic Technology, Pharmacokinetics, Pharmaceutical/Medicinal Chemistry, Computational Chemistry and Molecular Drug Design, Pharmacognosy and Phytochemistry, Herbal drugs/formulations, Pharmacology, Drug delivery, Pharmaceutical Analysis, Pharmacy Practice, Clinical and Hospital Pharmacy, Cell Biology, Genomics and Proteomics, Pharmacogenomics, Bioinformatics and Biotechnology of Pharmaceutical Interest.

  • Medical Science: Anatomy, Physiology, Biochemistry, Molecular Biology, Cell biology, Genetics, Hematology, Pathology, Immunology, Microbiology, Virology, Parasitology, Histopathology, Toxicology and all major disciplines of medical Sciences.

  • Chemical Sciences: Inorganic, physical, organic, analytical, theoretical, industrial, environmental and biological chemistry.

Instruction & Tips 


Copyright Form Download

Sample Article

Cover letter format

Instruction to Authors

How to submit?

Authors are required to submit manuscripts either through journal online process or as an e-mail attachment to submit@biopharmj.com or submittobiopharmj@gmail.com.

Initial submission

Prepare the text in Microsoft Word format. Submit the manuscript by sending us an e-mail to submit@biopharmj.com / submittobiopharmj@gmail.com and include the following information:

  • Contact information of the submitting author

  • Information about the authors (affiliation, postal address, e-mail address)

  • Tables and graphics separately in jpg-format (high quality) or Microsoft Excel

Additionally, please stick to the formal requirements presented below; especially concerning citation and graphics. Manuscripts disregarding the guidelines totally may be returned for revision prior to any reviewing activity.

Organization of the manuscript

These guidelines for research papers are flexible, especially for case studies. Manuscript is to be arranged in the following order:

  1. Title, author(s), and complete name(s) of institution(s)

  2. Abstract

  3. Introduction

  4. Materials and Methods

  5. Results (and discussion)

  6. Discussion

  7. References

To structure your manuscript, please try to restrict yourself to a maximum of three levels of headlines.

Title page

The title page has to contain the names of all authors and their complete mailing addresses with the corresponding author marked clearly. Please use an extra page for the title page.

Abstract:

Articles must include an Abstract of 250 words. The abstract should state briefly the purpose of the research, the principal results and major conclusions. Abstract should not repeat the information which is already present in the title. References should be avoided.

Key words

Immediately after the abstract, provide a maximum of 6 key words.

Introduction

The Introduction presents the purpose of the studies and relationship to previous work in the field. It is not required to incorporate an extensive review of the literature. Use only recent references and provide the most salient information to allow the readers to understand and evaluate the purpose and results of the present study.

Materials and Methods

The Materials and Methods section should be brief and concise with sufficient technical information. Only new methods should be described in detail. Cite previously published procedures in References.

Results

The Results section should include the rationale or design, optimization, validation of the experiments as well as the results of the experiments.

Discussion

Discussion section should focus on the interpretation of the results with proper justification. The Results and Discussion sections may be combined into one section.

References and footnotes (See Endnote style)

Maximum 35 and 75 references for original research paper/case study and review papers, respectively.

Citation in text

Please ensure that every reference cited in the text is also present in the reference list (and vice versa). Citations in the text contain only authors' names and year of publication (Author, Year) [e.g. (Leker, 2001), (Bröring and Leker, 2006) or (Bröring et al., 2006) when three or more authors].

Full references have to be included at the end of the paper in alphabetical order using the following style:

Book:

Author. (Year). Title,  Edition ed.  Publisher,  City.

Cooper, R.G., Edgett, S.J. and Kleinschmidt, E.J. (2001): Portfolio Management for New Products, 2nd ed., Perseus Publishing, Cambridge.

Book chapters:

Author. (Year): Title, in: Book Title, (Ed.)^(Eds.), Publisher. City, pp. Pages.

Leker, J. (2001): Strategie: Grundlagen und Anwendung, in: Betriebswirtschaftslehre für Chemiker: Eine Praxisorientierte Einführung, Festel, G., Hassan, A., Leker, J., Bamelis, P. (ed.), Springer. Berlin, pp. 74-88.

Journal papers:

Author. (Year). Title. Journal, Volume, Pages.

Bröring, S., Leker, J. and Rümer, S. (2006). Radicalor Not-Assessing Innovation in Established Firms. International Journal of Product Development, 3, p. 152-166.

 Online sources:

[name of author], [first letter of first name] ([year of publication]): [title], available at [address of website], accessed [date of last retrieval].

McGill, M. (2005): Biotechnology company goes public, available at http://www.online-newscenter. com/biotech_comp_goes_publ.html, accessed 16 June 2008.

Journal names may be abbreviated according to Chemical Abstracts. Authors are fully responsible for the accuracy of the references.

Tables and figures

Tables must have titles and sufficient empirical detail in a legend immediately following the title to be understandable without reference to the text. Each column in a table must have a heading, and abbreviations, when necessary, should be defined in the legend. Please number the tables.

Figures should have titles and explanatory legends containing sufficient detail to make the figure easily understood. Appropriately sized numbers, letters, and symbols should be used. The abscissa and ordinate should be clearly labeled with appropriately sized type.

Revision

Revise text in Microsoft Word 97 or a later version. Revise graphics at publication quality resolution. You may submit the revised manuscript as a single Microsoft Word document. Please send the revised manuscript via e-mail to the Editor who contacted you.

You will need:

  • Submission number

  • A cover letter with information for the Executive Editor and responses to raised concerns

  • Revised Manuscript

Publication

The Executive Editor responsible for your submission might ask you to change the format of your files in order to publish it. If the manuscript does not fulfill the formal requirements, the paper might be denied publication. Errors in a published paper will be corrected in the Journal of Business Administration in "Additions and Corrections".

Copyright

The submission of a manuscript by authors implies that they automatically agree to assign exclusive copyright to the Biopharm Journal (if the manuscript is accepted for publication). The work should not be published elsewhere in any form without the written permission of the journal. All rights of the articles published in the journal are reserved. No part of this publication may be reproduced, translated or transmitted in any form or by any means (electronic, mechanical or otherwise) without permission from the Biopharm Journal.

Ethics

Biopharm Journal insists on ethical practices in both human and animal experiments. Evidence for approval by a local Ethics Committee must be supplied by the authors on demand. Animal experimental procedures should be as humane as possible and the details of anaesthetics and analgesics used should be clearly stated. The ethical standards of experiments must be in accordance with the guidelines provided by the regulatory agencies of the respective country of authors. The journal will not consider any paper which is ethically unacceptable. A statement on ethics committee permission and ethical practices must be included in all research articles under the ‘Materials and Methods’ section.

Authors must be careful when they reproduce text, tables or illustrations from other sources. Plagiarism will be viewed seriously. Please see instructions below on this subject. All accepted papers are subject to editorial changes.

General Peer-Review Process

In short, all manuscripts submitted for publication in this journal are strictly and thoroughly peer-reviewed. The review process is single blind. If the manuscript is accepted for full review, it will be reviewed by a minimum of two external reviewers.

Submitted manuscripts will undergo a detailed initial check including a Plagiarism Check in the Editorial Office. An Editor – usually the managerial editor or a board member of the journal – together with the Editorial Office takes charge of the peer-review process. It starts with a Preliminary Review by the Editor (finished no more than 10 days after manuscript submission).

After a manuscript is accepted for full review, the Editor will collect at least two review comments and prepare a decision letter based on the comments of the reviewers (finished no more than 3 weeks after preliminary review). The decision letter is sent to the Corresponding Author to request an adequate revision (peer-reviewed again whenever necessary). The author will be asked to format the manuscript according to Journal’s template before it goes into typesetting and proofreading with the publisher. The author will receive the paper in PDF produced by Journal for checking before it is published online.

No charge for Article Submission

Biopharm Journal does NOT request ‘Article Submission Charges’ or ‘Submission Fees’.

Publication Charges

Biopharm Journal is an Open Access journal accessible for free on the Internet. It is herewith guaranteed that no university library or individual reader will ever have to buy a subscription or pay any pay-per-view fees to access articles in the electronic version of the journal. Hence, there is no revenue neither from the sale of subscriptions to the electronic version of the journal nor from pay-per-view fees. Yet, the online publication process does involve costs including those pertaining to setup and maintenance of the publication infrastructure, routine operation of the journal, processing of manuscripts through peer-reviews, editing, publishing, maintaining the scholarly record, and archiving. To cover these costs, the journal depends on Publication Fees. Publication fees are due when a manuscript has been accepted for publication.

Details of publication charge.
  • Regular publication charge is $ 100

  • Regular publication charge for Indian Authors is 2000

  • 25 % scholarship discount on the publication charge to the students or research scholars (provided they have send the proof from their authority or guide)

NOTE: For enquiry on mode of payment, write e-mail to managing editor at submit@biopharmj.com or submittobiopharmj@gmail.com.